After LBP intervention, theexpression levels of HO-1, NQO1 and Nrf2 were further increased with theincrease of LBP doses (P<0.01 when treated with 400 mg/kg and 800 mg/kg LBP,versus the LPS group). The gene discussed is HMOX1; the disease is Low back pain.